Asset Details
Do you wish to reserve the book?
Implantable photoelectrochemical-therapeutic methotrexate monitoring system with dual-atomic docking strategy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Implantable photoelectrochemical-therapeutic methotrexate monitoring system with dual-atomic docking strategy
Do you wish to request the book?
Implantable photoelectrochemical-therapeutic methotrexate monitoring system with dual-atomic docking strategy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Implantable photoelectrochemical-therapeutic methotrexate monitoring system with dual-atomic docking strategy
2025
Overview
The need for precise modulation of blood concentrations of pharmaceutical molecule, especially for high-risk drugs like Methotrexate (MTX), is underscored by the significant impact of individual variations on treatment efficacy. Achieving selective recognition of pharmaceutical molecules within the complex biological environment is a substantial challenge. To tackle this, we propose a synergistic atomic-molecular docking strategy that utilizes a hybrid-dual single-atom Fe1-Zn1 on a TiO2 photoelectrode to selectively bind to the carboxyl and aminopyrimidine groups of MTX respectively. By integrating this Fe
1
-Zn
1
-TiO
2
photoelectrode with a microcomputer system, an implantable photoelectrochemical-therapeutic drug monitoring (PEC-TDM) system is developed for real-time, continuous in vivo MTX monitoring. This system facilitates personalized therapeutic decision-making and intelligent drug delivery for individualized cancer therapy, potentially revolutionizing oncological care and enhancing patient outcomes.
Concentration of methotrexate (MTX) in the blood needs precise monitoring, Here, the authors propose an atomic-molecular docking strategy that utilizes a hybrid-dual single-atom Fe
1
-Zn
1
on TiO
2
photoelectrode to bind to the carboxyl and aminopyrimidine groups of MTX.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
